1 材料与方法
1.1 红三叶草的主要活性成分筛选与潜在靶点预测
1.2 家兔免疫应激靶点收集
1.3 蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络构建及关键靶点筛选
1.4 基因本体功能(GO)与京都基因与基因组百科全书(KEGG)通路富集分析
1.5 构建活性成分-靶点-免疫应激网络
1.6 分子对接验证
2 结果
2.1 红三叶草的主要活性成分筛选与潜在靶点预测结果
表1 红三叶草中29个活性成分信息Table 1 Information of 29 active components in red clover |
| 编号 No. | HERB数据库编号 HERB database No. | 化合物名称 Chemical compound name |
|---|---|---|
| 1 | HBIN003962 | 2,3-二甲基苯酚2,3-dicresol |
| 2 | HBIN005632 | 糠醛2-furaldehyde |
| 3 | HBIN005640 | 2-呋喃甲酸2-furancarboxylicacid |
| 4 | HBIN007430 | 3,4-二甲氧基苯甲酸3,4-dimethoxybenzoicacid |
| 5 | HBIN011862 | 5-O-甲基染料木素5-O-methylgenistein |
| 6 | HBIN015566 | α-铁(顺式) Alpha-iron (cis) |
| 7 | HBIN018523 | 鸡豆黄素Abiochanina |
| 8 | HBIN022577 | 大豆黄酮Daidzein |
| 9 | HBIN023694 | 双香豆素Dicoumarin |
| 10 | HBIN023881 | 黄颜木素Dihydrofisetin |
| 11 | HBIN026630 | 单叶芸香定Foliosidine |
| 12 | HBIN026662 | 刺芒柄花素Formononetin |
| 13 | HBIN026663 | 芒柄花素-7-葡萄糖苷Formononetin-7-glucoside |
| 14 | HBIN027456 | 染料木黄酮Genistein |
| 15 | HBIN030303 | 鸢尾蛋白Birilinb |
| 16 | HBIN030305 | 德鸢尾苷元Irilone |
| 17 | HBIN031114 | 异鼠李素Isorhamnetin |
| 18 | HBIN033803 | 木犀草素luteolin |
| 19 | HBIN034625 | 美迪紫檀素Medicarpin |
| 20 | HBIN034628 | 苜蓿紫檀酚-3-O-葡萄糖苷Medicarpin-3-O-glucoside |
| 21 | HBIN036774 | 假荆芥内酯Nepetalactone |
| 22 | HBIN038577 | 二氢樱黄素Padmakastein |
| 23 | HBIN038995 | 对香豆酸p-coumaricacid |
| 24 | HBIN039031 | 柳穿鱼素Pectolinarigenin |
| 25 | HBIN040658 | 红车轴草素Pratensein |
| 26 | HBIN040662 | 车轴草醇Pratol |
| 27 | HBIN041013 | 野靛黄素Pseudobaptigenin |
| 28 | HBIN041495 | 槲皮素Quercetin |
| 29 | HBIN047035 | 红车轴草根苷Trifolirhizin |
2.2 红三叶草抑制家兔免疫应激靶点分析
图1 红三叶草活性成分-潜在靶点网络图仅列出靶点中度值排名前10的靶点名称 List only the top 10 target names in degree values。CYP19A1:芳香酶 aromatase;CA12:碳酸酐酶12 carbonic anhydrase 12;CA1:碳酸酐酶 1 carbonic anhydrase 1;CA2:碳酸酐酶2 carbonic anhydrase 2;ESR2:雌激素β受体 estrogen receptor beta;ADORA1:腺苷受体A1 adenosine receptor A1;CA4:碳酸酐酶4 carbonic anhydrase 4;CA7:碳酸酐酶7 carbonic anhydrase 7;TYR:酪氨酸酶 tyrosinase;MAOA:胺氧化酶[含黄素]A amine oxidase [flavin-containing] A。 Fig.1 Network diagram of active ingredient of red clover-potential target |
2.3 构建PPI网络
图3 红三叶草作用于家兔免疫应激靶点的PPI网络图A:PPI网络图;B:PPI网络图可视化。 Fig.3 PPI network diagram of red clover acting on immune stress targets in rabbits A: PPI network diagram;B: PPI network diagram visualization. |
图4 红三叶草作用家兔免疫应激核心靶点图仅列出靶点中度值排名前10的靶点名称 List only the top 10 target names in degree values。CASP3:半胱天冬酶3 caspase 3;EGFR:表皮生长因子受体 epidermal receptor growth factor;ESR1:雌激素受体1 strogen receptor 1;SRC:原癌酪氨酸蛋白激酶 proto-oncotyrosine protein kinase;MMP9:基质金属蛋白酶9 matrix metalloproteinase 9;PTGS2:前列腺素G/H合酶2 prostaglandin G/H synthase 2;PPARG:过氧化物酶体增殖物激活受体γ peroxisome proliferator-activated receptor γ;TLR4:Toll样受体4 Toll-like receptor 4;PIK3CA:磷脂酰肌醇4,5-二磷酸3-激酶催化亚基α亚型 phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit α isoform;FYN:酪氨酸蛋白激酶Fyn tyrosine protein kinase Fyn。 Fig.4 Diagram of key targets of red clover on immune stress in rabbits |
2.4 构建活性成分-靶点-免疫应激网络
2.5 GO功能注释分析与KEGG通路富集分析
图6 核心靶点的GO功能分析Biological process:生物过程;phosphorylation:磷酸化;protein phosphorylation:蛋白质磷酸化;insulin-like growth factor receptor signaling pathway:胰岛素样生长因子受体信号通路;cellular response to cadmium ion:细胞对镉离子的反应;cellular response to amyloid-beta:细胞对淀粉样蛋白的反应;negative regulation of protein catabolic process:负向调节蛋白质分解代谢过程;protein destabilization:蛋白质去稳定化;cellular response to reactive oxygen species:细胞对活性氧的反应;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction:磷脂酰肌醇3-激酶/蛋白激酶B信号转导的正调控;positive regulation of non-canonical NF-kappaB signal transduction:非经典核转录因子-κB信号转导的正向调控;Cellular component:细胞组分;perinuclear region of cytoplasm:细胞质核周区;cytosol:胞质;nucleus:细胞核;axon:轴突;cytoplasm:细胞质;early endosome:早期内体;melanosome:黑色素颗粒;protein-containing complex:含蛋白质的复合物;insulin receptor complex:胰岛素受体复合物;late endosome:晚期内体;Molecular function:分子功能;identical protein binding:相同的蛋白质结合;ATP binding:ATP结合;insulin receptor substrate binding:胰岛素受体底物结合;estrogen response element binding:雌激素反应元件结合;nuclear receptor activity:核受体活性;protein serine kinase activity:蛋白质丝氨酸激酶活性;disordered domain specific binding:无序结构域特异性结合;steroid binding:甾体结合;signaling receptor binding:信号受体结合;cyclin binding:细胞周期蛋白结合。 Fig.6 GO functional analysis of core targets |
图7 核心靶点的KEGG通路富集分析Pathways in cancer:癌症通路;Prostate cancer:前列腺癌;Endocrine resistance:内分泌治疗耐药;Estrogen signaling pathway:雌激素信号通路;PI3K-Akt signaling pathway:磷脂酰肌醇3-激酶-蛋白激酶B通路;Breast cancer:乳腺癌;Lipid and atherosclerosis:脂质和动脉粥样硬化;Glioma:胶质瘤;Chemical carcinogenesis-receptor activation:化学致癌-受体激活;IL-17 signaling pathway:白细胞介素-17信号通路。 Fig.7 KEGG pathway enrichment analysis of core targets |
2.6 分子对接验证
表2 核心靶点与相应成分分子对接结果Table 2 Results of molecular docking of core targets and corresponding components |
| 靶点 Targets | PDB数据库蛋白质 PDB database protein | 编号 No. | 结合能 Binding energy/(kJ/mol) |
|---|---|---|---|
半胱天冬酶3 CASP3 | 1NME | 19 | -26.36 |
| 20 | -30.12 | ||
表皮生长因子受体 EGFR | 2EB2 | 5 | -28.45 |
| 7 | -29.29 | ||
| 8 | -29.29 | ||
| 12 | -28.87 | ||
| 14 | -29.71 | ||
| 15 | -30.12 | ||
| 16 | -30.96 | ||
| 17 | -30.96 | ||
| 18 | -32.64 | ||
| 20 | -33.05 | ||
| 22 | -29.29 | ||
| 24 | -29.29 | ||
| 25 | -29.29 | ||
| 27 | -34.31 | ||
| 28 | -30.96 | ||
雌激素受体1 ESR1 | 7RS8 | 1 | -23.43 |
| 5 | -34.31 | ||
| 7 | -32.22 | ||
| 8 | -34.31 | ||
| 12 | -32.22 | ||
| 14 | -33.89 | ||
| 15 | -30.96 | ||
| 16 | -32.64 | ||
| 18 | -34.73 | ||
| 19 | -35.15 | ||
| 22 | -29.29 | ||
| 23 | -24.69 | ||
| 24 | -29.71 | ||
| 25 | -33.89 | ||
| 26 | -34.31 | ||
| 27 | -32.64 |
图8 靶点与化合物分子对接模式图a:EGFR-苜蓿紫檀酚-3-O-葡萄糖苷 EGFR-medicarpin-3-o-glucoside;b:EGFR-野靛黄素 EGFR-pseudobaptigenin;c:ESR1-5-O-甲基染料木素 ESR1-5-O-methylgenistein;d:ESR1-大豆黄酮 ESR1-daidzein;e:ESR1-染料木黄酮 ESR1-genistein;f:ESR1-德鸢尾苷元 ESR1-irilone;g:ESR1-木犀草素 ESR1-luteolin;h:ESR1-美迪紫檀素 ESR1-medicarpin;i:ESR1-红车轴草素 ESR1-pratensein;j:ESR1-车轴草醇 ESR1-pratol。 Fig.8 Docking pattern diagram of target and compound molecules |
